Seattle Layoff Update: Amgen, Isilon Cut Staff

4/10/09Follow @gthuang

The carnage continues at tech and life sciences companies in the Northwest. You can follow Xconomy Seattle’s updated layoff litany here—we’ve kept a running tally of job cuts since November. (If you’ve heard of other layoffs in the innovation community, please drop us a line at tips@xconomy.com or gthuang@xconomy.com.)

—Luke broke the news that Amgen (NASDAQ: AMGN), the world’s largest biotech company, is cutting 100 jobs at its drug manufacturing facility in Bothell, WA. The layoff will be effective in July, and will leave about 70 Amgen workers still employed in Bothell, and just under 900 in Washington state. Amgen said it is merging the work being done in Bothell into a larger facility at company headquarters in Thousand Oaks, CA.

—Seattle-based Isilon Systems (NASDAQ: ISLN), a data storage and virtualization company, is laying off 10 percent of its global workforce (about 40 workers) in an effort to save about $4 million a year. Isilon didn’t specify how many positions were cut in Seattle, but the company had 394 employees at the end of 2008.

—Theraclone Sciences (formerly Spaltudaq), a Seattle biotech startup working on an antibody drug for HIV, had a small layoff in the past few months. To our knowledge, this wasn’t reported elsewhere. Theraclone now has about 22 employees and enough cash to last through 2010, as Luke reported this week.

Gregory T. Huang is Xconomy's Deputy Editor, National IT Editor, and the Editor of Xconomy Boston. You can e-mail him at gthuang@xconomy.com. Follow @gthuang

By posting a comment, you agree to our terms and conditions.